fashion -WSS

fashion

author：explore 2025-09-08 11:05:10 - browse：94

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： The nurse manager staffing crisis is hurting patients

WSS

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Fauci’s Covid grilling leads GOP to weigh foreign research rules

How I ended up pumping milk in a bathroom stall at JPM 2024

Designating disabled people as health disparity population is crucial

New England Journal of Medicine addresses racist history, slavery

New Medicare drug pricing powers could soon be upended in court

hotspot

fashion

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Questions and answers about ramping up H5N1 bird flu vaccine

23andMe had bad news about my health. I wish a person had delivered it

Addressing health care workers' trauma can help fight burnout

After affirmative action ruling, medical educators look to 'holistic review'

Scrutiny of post

Sports medicine is finally prioritizing gender equality

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

New air purifier tech could be key to improving indoor air quality

Heart disease and mental health: A look at cardiac psychology

focus

Digital health: a case of mistaken identity

UnitedHealth argues against case alleging wrongful AI care denials

Investigation reveals sickle cell patients pressured into sterilizations

New menopause drug shows promise in relief for hot flashes

FDA poised to publish guidelines for clinical trial diversity

Designating disabled people as health disparity population is crucial

knowledge

explore

entertainment

explore